Essilor® Stellest® Lenses

Slow myopia progression
Slowed myopia progression by 71% on average^2 3

Correct myopia
Correct myopia with single vision zone to ensure sharp vision

Easy to use and proven^5 6
An easy-to-use and proven⁷ way to help manage your child’s nearsightedness

Essilor® Stellest® lenses are Essilor®’s breakthrough⁸ innovation to slow myopia progression in children. Essilor® Stellest® lenses are the first and only FDA market-authorized spectacle lens to slow the progression of nearsightedness in children.^9 10.

References:

1. Essilor International, data on file (2025).
2. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
3. Essilor International, data on file (2025).
4. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
5. Essilor International, data on file (2025).
6. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
7. Essilor International, data on file (2025).
8. The U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to the Essilor® Stellest® spectacle lens in April 2021.
9. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
10. Essilor International, data on file (2025).